Targeted Therapy Promising for Rare Hematologic Cancer
Tagraxofusp seems effective for treating blastic plasmacytoid dendritic-cell neoplasm
Single-Dose Brachytherapy Effective for Prostate Cancer
Two-year and three-year biochemical progression-free survival rate of 100 percent for low-risk disease
Telerehabilitation Aids Function, Pain With Advanced Cancer
But the addition of pharmacological pain management did not offer further benefit
Gender Differences Seen in Adverse Drug Reactions
Differences found in reaction symptoms and types of drugs tied to adverse reactions
Improvement Needed in Doctor-Patient Lung Cancer Screening Discussions
Crude estimated rates of physician-patient discussion dropped from 6.7 to 4.3 percent in 2012 to 2017
Six Prognostic Factors ID’d for Invasive Disease After DCIS
Six significant factors include African-American race, premenopausal status, detection by palpation
Sucking Ice Chips Cuts Oral Side Effects of Oxaliplatin Chemo
Benefits include less trouble eating and fewer symptom-related negative effects on quality of life
Personalizing Breast Cancer Tx Could Cut Initial Costs of Care
Small decline seen in costs in first 12 months of care with personalized treatment based on recurrence scores
CDC Provides Clarification of Opioid Prescribing Guideline
Misapplication of the guideline can put patient health and safety at risk
Outcomes Worse for Cancer Patients Seen at Noncancer EDs
Patients who visit ED at alternative hospital or noncancer center at increased risk for worse outcomes
